Aphale P, Dokania S, Shekhar H. Comment on "Long-Term Safety and Efficacy of the Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Injection in Patients With HER2-Positive Early Breast Cancer in PHranceSCa, a Randomized, Open-Label Phase II Study". Clin Breast Cancer 2025 Sep 21:S1526-8209(25)00280.
PMID: 41087206